- Display 15 Products per page
Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems
Published: November 1, 2011 | Price: $150.00 – $300.00
Radiography includes mammography, computed tomography, traditional x-ray and digital x-ray. These imaging procedures are affected by a number of factors: advances in technology, consumer expectations for healthcare, declining reimbursement and coverage of medical expenses by insurance companies and the aging of the population are among the factors driving these imaging markets. This report, Medical Imaging Markets: X-Ray, Digital X-Ray, CT and Other Radiography Systems from Kalorama Information, details these factors and provides 2011 market size and forecast to 2015 for...
Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003
Published: March 1, 2004 | Price: $795.00 – $1,590.00
The hard-fought battle over Medicare's prescription drug benefit is over, but the long-term effects of the new law are still unclear. Exactly who will benefit and by how much? Is it a victory for big pharma? Initial reactions are not always correct, and this examination into the true implications for pharmaceutical markets looks at all the facts. This market briefing from Kalorama describes and assesses the provisions of the "Medicare Prescription Drug, Improvement and Modernization Act of 2003" and predicts...
Men’s Health – The Market for Current and Emerging Drug Therapies, 2nd Edition
Published: May 1, 2006 | Price: $3,550.00 – $7,000.00
This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments: Men’s Cancer Men’s Sexual Dysfunction Men’s Sexually Transmitted Diseases Men’s Urinary Conditions Andropause The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic hyperplasia (BPH), urinary incontinence, and STD’s such as HIV, herpes, and genital warts. For each segment, revenues and forecasts are made by type of drug through 2010; competitive market share of the...
Men’s Health: The World Market for Current and Emerging Drug Therapies
Published: August 1, 2003 | Price: $2,625.00 – $5,250.00
This Kalorama Information report—Men’s Health: The World Market for Current and Emerging Drug Therapies—focuses on treatment segments in which men are affected. These segments include: · Men’s Cancer · Sexual Function · Sexually Transmitted Diseases · Urinary Conditions · Andropause The report covers drugs that are used for the treatment of conditions affecting men, including prostate cancer, impotence, and BPH; and areas where diseases and men’s health are a major concern including HIV, herpes, and urinary incontinence. Revenues for product...
Mergers and Acquisitions in the IVD Market
Published: February 17, 2015 | Price: $500.00 – $1,000.00
IVD Mergers and Acquisitions Kalorama Information continously tracks mergers and acquisitons in the IVD market. This report IVD Mergers and Acquisitions, records and details 130 significant acquisitions that have taken place from 2012 to early 2015. Companies are the future of the industry lies in the development of more accurate, faster, usable devices. It also involves devices that are IT capable. It’s impossible for eve the largest companies to own all of the innovative technology, so M&A is an important...
Mergers and Acquisitions in the IVD Market
Published: January 10, 2017 | Price: $796.00 – $1,592.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions (M&A) activity in the in vitro diagnostics (IVD) market was brisk in 2016. Kalorama's report records 250 acquisitions in the industry from 2013-2016. Becton Dickinson (BD), Danaher, Roche, and Thermo Fisher Scientific were among the companies active in M&A during this period.
Mergers and Acquisitions in the IVD Market
Published: March 27, 2018 | Price: $995.00 – $1,990.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market records over 220 acquisitions in the in vitro diagnostics (IVD) industry in total, featuring approximately 152 purchase arrangements in 2015-2016 and 69 acquisitions in IVD and related segments so far from 2017 to March 2018. Among the leading diagnostics companies looking to increase market share and produce revenue growth via acquisition are Abbott/Alere, Beckman Coulter / Danaher, and Roche. Abbott's acquisition of Alere and related divestures...
Mergers and Acquisitions in the IVD Market
Published: June 28, 2019 | Price: $2,000.00 – $4,000.00
In vitro diagnostic (IVD) products continue to see positive sales growth in many categories. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. In this environment, companies are making strategic acquisitions that simultaneously add a revenue stream and product innovation. Kalorama Information looks at these market transactions in Mergers and Acquisitions in the IVD Market, recording more than 220 acquisitions in the diagnostics...
Mergers and Acquisitions in the IVD Market, October 2015
Published: October 26, 2015 | Price: $499.00 – $1,000.00
Mergers and Acquisitions in the IVD Market Mergers and Acquisitions in the IVD Market documents some 240 acquisitions that have taken place from 2012 to October 2015 in the extremely dynamic IVD industry. And this is likely only a small portion of what is really happening in the market; more deals are still to come. In vitro diagnostic (IVD) companies have been very busy with respect to acquisitions in an attempt to augment market share in an increasingly competitive market....
Mexico IVD Market Analysis
Published: July 25, 2017 | Price: $2,800.00 – $5,600.00
Mexico IVD Market Analysis In Mexico, there is a growing demand for new technologies in the laboratory sector and, as government and private hospital budgets increase, the market is expected to see an increase in demand for high-tech equipment and consumables. Mexico IVD Market Analysis focuses on the in vitro diagnostic (IVD) discipline including revenue data on the major market sub-segments for 2016-2021: In Vitro Diagnostic Sales by Market Segment (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose,...
mhealth Markets Worldwide: Forecasts to 2020
Published: July 8, 2015 | Price: $499.00 – $1,000.00
Mobile Health Device (mhealth) Markets Mobile health, or mHealth, can be loosely defined as the evaluation and delivery of healthcare using mobile and wireless devices. However, despite its simple description, the mHealth segment involves a complex and wide range of services, devices, software products, regulatory webs, market participants and end users. This complex framework requires the coordination of several parties and compatibility of several systems to provide a seamless network of health delivery. The process of mobile health involves using...
MicroRNA Tools and Services Market
Published: May 3, 2016 | Price: $3,360.00 – $6,720.00
MicroRNA Tools and Services Market MicroRNA Tools and Services Market analyzes the miRNA marketplace and contains the following data: estimated revenue breakdown by tools and services, 2015; estimated revenue breakdown by geographic region, 2015 (North America, Europe, rest of world); world market and projections for miRNA tools and services, 2013-2016 and 2020 (miRNA analysis tools, miRNA services, total revenues); world market and projections for miRNA analysis tools and services by region, 2013-2016 and 2020 (North America, Europe, rest of world,...
Minimally Invasive Spinal Surgery – A Market Briefing
Published: June 1, 2005 | Price: $995.00 – $1,990.00
With the promise of improved outcomes and shorter recovery times and costs, endoscopic surgery has evolved into an accepted surgical discipline in most therapeutic areas. However, spine surgeons in particular have been slow to embrace this new technology over the past decade or so. Challenges specific to the spinal column have made the adoption of minimally invasive surgery difficult, but endoscope manufacturers have begun to take advantage of technological advances in endoscopic visualization and other arrears to optimize the minimal-access...
Minimally Invasive Surgical Devices, World Market
Published: September 1, 2008 | Price: $3,500.00 – $7,000.00
Minimally invasive surgery (MIS) allows doctors to perform many complicated operations with a short hospital stay. It is a safe, feasible, and patient-friendly method of performing an operation. The report includes product information, procedure volume data, world demographics; and other general issues affecting the MIS device market. Information is presented as a worldwide overview, with a focus on the US. A market summary includes market analysis by intended use and a competitive analysis of leading providers. Additionally key company profiles...
miRNA Research and Diagnostics Markets: Forecast to 2019
Published: September 4, 2014 | Price: $995.00 – $1,990.00
miRNA Research and Diagnostics Markets This report, miRNA Research and Diagnostic Markets, focuses on the test product potential of microRNA. These pieces of RNA are seen as important regulators of gene expression; including growth, form, differentiation, and apoptosis. They serve myriad functions as regulator molecules in post-transcriptional gene silencing. As the study details, a wide range of companies, both small biotechs and big pharmaceutical companies are committed to miRNA diagnostics. As part of its coverage of this topic, this report...